Article Details

Acceleron Pharma Inc. (NASDAQ:XLRN) Given Average Rating of "Buy" by Analysts

Retrieved on: 2021-06-24 07:18:45

Tags for this article:

Click the tags to see associated articles and topics

Acceleron Pharma Inc. (NASDAQ:XLRN) Given Average Rating of "Buy" by Analysts. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 4,628,978 shares of the biopharmaceutical company's stock worth $627,737,000 after purchasing an additional 17,164 shares ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo